Table 5. Cumulative event rates, crude and adjusted hazard ratios (HR) and 95% confidence intervals (CI) for one-year adverse outcomes.

Adverse outcome (%)	Event Rates		Unadjusted Model			Adjusted Model¹			Adjusted Model²
	No SLE	SLE	HR	95% CI	p-value	HR	95% CI	p-value	HR	95% CI	p-value
Death	5.0	3.8	0.76	0.11-5.42	0.78	1.10	0.15-8.01	0.93	1.53	0.21-11.17	0.67
MI ^*	4.8	15.6	3.28	1.21-8.85	0.02	3.62	1.30-10.04	0.01	3.58	1.28-10.02	0.01
CABG	4.0	7.8	2.00	0.50-8.10	0.33	0.99	0.24-4.14	0.99	1.19	0.29-4.93	0.81
Death or MI	9.4	19.2	2.12	0.88-5.12	0.09	2.59	1.05-6.38	0.04	2.47	1.00-6.10	0.05
Death or MI or CABG	12.5	19.2	1.57	0.65-3.80	0.31	1.48	0.60-3.62	0.39	1.50	0.61-3.67	0.37
Repeat PCI ^†	11.8	31.3	3.13	1.55-6.31	0.001	2.40	1.17-4.91	0.02	2.65	1.28-5.49	0.009
Repeat revascularization ^*	15.0	31.3	2.39	1.19-4.80	0.01	1.64	0.80-3.35	0.17	1.98	0.97-4.06	0.06
MACE	21.2	34.6	1.78	0.92-3.44	0.08	1.48	0.76-2.88	0.25	1.55	0.79-3.03	0.20

MI = myocardial infarction, CABG = coronary artery bypass graft surgery, PCI = percutaneous coronary intervention, MACE = major adverse coronary event - includes death, MI, CABG or need for repeat PCI Repeat revascularization includes need for CABG or repeat PCI

Event rate comparisons:

p=0.01

^†

p<0.001

All models adjusted for age, sex, primary reason for revascularization, history of myocardial infarction, acuity of procedure, vessel disease, and recruitment wave (drug eluting stent era vs bare metal stent era).

Models adjusted for age, sex, recruitment wave (drug eluting stent era vs bare metal stent era), and outcome-specific risk factors.